<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infections</z:e> may act as environmental triggers for the induction of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we determine the relationship between disease manifestations of SLE patients and the titers of five Epstein-Barr virus (EBV) Abs </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated the titers of early antigen IgG (EAG), nuclear antigen IgG, <z:mp ids='MP_0001799'>viral</z:mp> capsid antigen (VCA) IgG and IgM, and heterophile IgM, using the BioPlex 2200 multiplexed immunoassay method in 260 sera (120 SLE patients and 140 controls) </plain></SENT>
<SENT sid="3" pm="."><plain>EAG titers were significantly elevated (P &lt; 0.024) in patients with cutaneous symptoms and increased anti-Ro antibody titers (P &lt; 0.005) </plain></SENT>
<SENT sid="4" pm="."><plain>VCA IgG titers were significantly elevated (P &lt; 0.003) in patients with joint involvement </plain></SENT>
<SENT sid="5" pm="."><plain>None of the titers differed by central <z:mp ids='MP_0008912'>nervous</z:mp> system or renal involvement or <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that exposure to <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> may predict a disease phenotype of mild SLE disease with cutaneous and joint manifestations and elevated titers of anti-Ro Abs </plain></SENT>
</text></document>